IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,949,190 | +10.5% | 43,000 | 0.0% | 0.66% | +22.3% |
| Q2 2023 | $1,763,860 | +14.7% | 43,000 | 0.0% | 0.54% | +25.2% |
| Q1 2023 | $1,537,250 | -96.7% | 43,000 | +2425.0% | 0.43% | -10.8% |
| Q2 2022 | $46,088,000 | +1297.0% | 1,703 | -98.9% | 0.48% | -35.3% |
| Q1 2022 | $3,299,000 | -69.5% | 154,088 | -56.6% | 0.74% | -69.1% |
| Q4 2021 | $10,805,000 | +619.4% | 355,088 | +692.9% | 2.41% | +564.9% |
| Q3 2021 | $1,502,000 | -79.3% | 44,781 | -75.4% | 0.36% | -81.1% |
| Q2 2021 | $7,251,000 | -51.7% | 181,781 | -45.5% | 1.91% | -51.8% |
| Q1 2021 | $15,003,000 | +241.1% | 333,781 | +329.1% | 3.97% | +230.4% |
| Q4 2020 | $4,398,000 | +132.9% | 77,781 | +95.5% | 1.20% | +97.2% |
| Q3 2020 | $1,888,000 | -20.1% | 39,781 | 0.0% | 0.61% | -22.4% |
| Q2 2020 | $2,363,000 | -7.1% | 39,781 | -26.0% | 0.78% | -32.3% |
| Q1 2020 | $2,543,000 | -21.7% | 53,781 | 0.0% | 1.16% | -0.9% |
| Q4 2019 | $3,246,000 | +17.3% | 53,781 | +16.5% | 1.17% | -8.6% |
| Q3 2019 | $2,767,000 | -48.0% | 46,181 | -44.2% | 1.28% | -35.2% |
| Q2 2019 | $5,320,000 | +37.2% | 82,781 | +73.3% | 1.97% | +37.8% |
| Q1 2019 | $3,877,000 | +128.3% | 47,781 | +19.5% | 1.43% | +35.9% |
| Q4 2018 | $1,698,000 | -16.6% | 40,000 | -22.3% | 1.05% | +8.9% |
| Q3 2018 | $2,037,000 | -61.4% | 51,500 | -59.3% | 0.97% | -52.2% |
| Q2 2018 | $5,271,000 | -5.5% | 126,500 | 0.0% | 2.02% | -6.9% |
| Q1 2018 | $5,576,000 | +115.4% | 126,500 | +145.6% | 2.18% | +138.2% |
| Q4 2017 | $2,589,000 | -0.8% | 51,500 | 0.0% | 0.91% | -10.1% |
| Q3 2017 | $2,611,000 | -0.3% | 51,500 | 0.0% | 1.02% | +2.0% |
| Q2 2017 | $2,620,000 | +26.6% | 51,500 | 0.0% | 1.00% | +25.8% |
| Q1 2017 | $2,070,000 | – | 51,500 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |